Objectives. Comparisons of cancer survival in Canadian and US metropolitan areas have shown consistent Canadian advantages. This study tests a health insurance hypothesis by comparing cancer survival in Toronto, Ontario, and Honolulu, Hawaii.
Methods. Ontario and Hawaii registries provided a total of 9190 and 2895 cancer cases (breast and prostate, 1986-1990, followed until 1996) . Socioeconomic data for each person's residence at the time of diagnosis were taken from population censuses.
Results. Socioeconomic status and cancer survival were directly associated in the US cohort, but not in the Canadian cohort. Compared with similar patients in Honolulu, residents of lowincome areas in Toronto experienced 5-year survival advantages for breast and prostate cancer. In support of the health insurance hypothesis, between-country differences were smaller than those observed with other state samples and the Canadian advantage was larger among younger women.
Conclusions. Hawaii seems to provide better cancer care than many other states, but patients in Toronto still enjoy a significant survival advantage. Although Hawaii's employer-mandated health insurance coverage seems an effective step toward providing equitable health care, even better care could be expected with a universally accessible, single-payer system. (Am J Public Health. 2000;90:1866-1872)
A recent study of cancer survival in Toronto, Ontario, and in Detroit, Michigan, compared their ecologically defined poor and found advantaged survival among Canadians for 13 of 15 cancer sites (weighted mean 5year survival rate ratio [SRR]=1.55). 1, 2 This consistent pattern of Canadian cancer survival advantage was then systematically replicated with 3 more economically resourceful US metropolitan areas (Seattle, Wash; San Francisco, Calif; and Hartford, Conn). 3 Again, significantly better 5-year survival rates were observed for 13 of 15 common types of cancer among the relatively poor of Toronto compared with similarly poor US subjects (SRR=1. 35) . Moreover, no such between-country differentials were observed in the middle-or highincome groups. Cancer survival reported in the first Canada-US comparative study in this research field was substantively similar. 4 However, that study's essentially nonsignificant findings are not surprising, as it did not include any measure of socioeconomic status (SES). It merely compared cohorts across all aggregated SES levels and so could not observe any modification of between-country survival differences by SES.
Another recent study, which systematically replicated Canadian cancer survival advantages among those who live in relatively poor communities, probably compromised internal validity in its attempt to extend external validity. 5 Its aggregate comparison of the province of Ontario with a sample of the entire United States may have been confounded by other than socioeconomic variability related to the diverse metropolitan, exurban, and rural residences represented among its samples or, relatedly, by the size of its ecologic units of analysis, which ranged by a factor of more than 1000, from smaller areal units (e.g., census tract, 0.5 km 2 ) typical of metropolitan areas to much larger census subdivision or county units (e.g., 500 km 2 ) more typically used in other areas. The present study attempts to extend this research field's external validity without making such compromises.
The central inference has been that a key structural difference between Canada and the United States-single-payer vs multipayer health care systems-is the most cogent explanation for the observed consistent pattern of Canadian survival advantage across various cancer sites; that is, the more equitable access they offer to preventive and therapeutic health care services is responsible for the differences. In the United States, insurance status-noninsured or underinsured vs some insurance or better insured-has been found to be strongly associated with the receipt of primary care, the receipt of cancer screening services, stage of cancer at the time of diagnosis, 6-15 receipt of various cancer treatments, [16] [17] [18] [19] [20] and survival of cancer (weighted risk ratios consistent with disadvantage among the uninsured ranged from 1.50 to 10.00). [21] [22] [23] [24] [25] [26] Cancer care in Canada has not been without its apparent inequities. For example, a socioeconomic mammography gradient, albeit much smaller than the US one, was observed in Canada in the mid-1980s along with evidence of higher screening rates among American women. 27, 28 More recent samples, however, have demonstrated that federal and provincial initiatives have substantially reduced or eliminated these inequities. 29 The fact that the more prevalent screening participation among American women was not attendant with earlier stage at diagnosis or survival advantages underscores the probable importance of other prevention strategies such as the opportunity to develop an ongoing, continuous relationship with a primary care physician. Such more generalist life-course preventive interventions probably are more readily available in Canada, particularly among the relatively poor. Given that previous studies have provided substantial adjustments for absolute income status, race/ethnicity and culture, differential longevity, and competing causes of death and that the consistent pattern of the Canadian advantage has been observed across divergent types of cancer (e.g., some associated with lifestyle, others not), the developing health insurance theory certainly seems to hold prima facie validity.
The present analysis tests the health insurance hypothesis by means of a systematic replication of previous Canada (Toronto)-US cancer survival comparisons with a US metropolitan sample from Hawaii, a state that is atypical in its history of offering health insurance coverage to its residents. Hawaii has mandated employer-based health insurance coverage since 1974, and through related legislation it has also endeavored to insure people employed part-time as well as those unemployed. Estimates of Hawaii's prevalent health insurance coverage have ranged from 89% to 98% (median estimate=96%). [30] [31] [32] [33] [34] Such a legislative mandate has not guaranteed everyone health insurance, and Hawaii has not been able to completely eliminate all health status inequities (traditional "at-risk" groups [e.g., Native Hawaiians] and geographic service variabilities still exist). Nevertheless, Hawaii seems to stand alone among US states in minimizing the risk of being uninsured. During the mid-1980s to the mid-1990s, the period during which the international research on cancer survival was performed, the prevalence of Hawaii's uninsured typically has been half to one quarter that of most other states. We therefore hypothesized that relatively poor Hawaiians would enjoy a cancer survival experience more similar to that of their relatively poor Canadian counterparts, although we still hypothesized advantaged survival among Canadians.
Methods
Cancer cases arose from the populations of greater metropolitan Toronto, Ontario (Toronto, York, and Peel regions; population 3.5 million in 1991), and Honolulu, Hawaii (Honolulu County; population 825 000 in 1991). 35, 36 Metropolitan samples were selected to provide some control for natural health care service endowment. Physician and hospitalbased preventive, investigative, and therapeutic oncology services, although they may not be equitably accessible, are well known as the most available in such areas of Canada and the United States. The data sources were the Ontario Cancer Registry (Toronto data) and the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program (Honolulu data). Definitions of the study cohorts were constrained by the following: 1986 was the first year in which the Ontario Cancer Registry coded the postal code of residence for most cases, and cohort termination or the date of last follow-up for both cohorts was December 31, 1995. 37,38 A 5-year survival analysis was based on cumulative incident cases diagnosed from 1986 to 1990. Power calculations based on the between-country comparisons reported in the original Toronto-Detroit study as well as 3 statistical criteria (2-tailed test; power, defined as [1-β]=.80; and α=.05 [95% confidence intervals]) 1, 39 determined that there would be sufficient power to detect meaningful between-country differences for breast and prostate cancer, the 2 most common types of cancer for which preventive and therapeutic interventions are expected to make a difference. All primary malignant cancers of the breast among women and of the prostate among men that occurred in adults (25 years or older) were included in the analysis (5807 breast and 3383 prostate cancer cases in Toronto and 1783 breast and 1112 prostate cancer cases in Honolulu).
The present analysis, like the original, used a census-based SES measure (census tract proportion meeting a "low-income" criterion in Canada and "poverty" threshold in the United States) to define relative income quantiles. 35, 36 Its critical comparisons were therefore between corresponding income tertiles and deciles in Toronto and Honolulu. Descriptive profiles of the resultant income areas that are displayed in Table 1 demonstrate 2 methodologically important principles: (1) the construct validity of this study's ecologic measures of relative SES is supported by the clear median income hierarchies-relatively low to high income areasobserved in bothToronto and Honolulu, and (2) even though Statistics Canada's low-income criterion is much more liberal than the US Census Bureau's poverty threshold, the corresponding Toronto-Honolulu relative income areas are strikingly similar in terms of their typical incomes (and population sizes and areas; see Table 1 footnotes a and b), providing substantial ecologic control for absolute economic status. This study's Honolulu cohort was nearly identical to the original Toronto and other US cohorts on data quality indicators: 97.5% of their residences (census tracts) at the time of diagnosis were coded, 95.9% of the cancers were microscopically confirmed, and 0.8% were enumerated on the basis of death certificates only. 37, 38 Analytically, the present study's 5-year survival analysis was a near-exact replicate of the original. Survival rates were directly age adjusted on the basis of this study's combined Toronto-Honolulu population of cases by each specific cancer site across the following age strata: 25-44, 45-54, 55-64, 65-74, and 75 years or older. Among all the breast and prostate cancer cases in which the patient was dead at follow-up, 79% and 63%, respectively, of the patients died as a direct result of cancer. Among the sample of cases diagnosed before 65 years of age, however, nearly all subsequent deaths were attributable to cancer (90% and 81%, respectively). Cancer survival comparisons across specific income area strata were then performed, so that SRRs were greater than 1.00 if Toronto residents were advantaged and less than 1.00 if Honolulu residents were advantaged. Ninety-five-percent confidence intervals around survival rate ratios were based on the Mantel-Haenszel χ 2 test. 40, 41 Throughout the text, when referring to SRR point estimates that "approached statistical significance," we specifically mean that although their associated 95% confidence intervals intersected the null (not significant at α=.05), their corresponding 90% confidence intervals did not (significant at α=.10).
Results
This study systematically replicated the findings of previous Canadian-US cancer survival analyses across socioeconomic tertileslow-, middle-, and high-income areas-in the following 3 ways (top of Table 2 ).
1. The Toronto samples of breast and prostate cancer cases that extended previous analyses by 2 years continued to demonstrate no association between SES and cancer survival, whereas the Honolulu samples did; 5year survival rates were significantly lower in Honolulu's relatively low-income areas (breast and prostate cancer low-income vs high-income SRRs were 0.94 and 0.85, respectively).
2. The 2 countries' samples did not differ significantly on cancer survival in the middleor high-income groups.
3. As hypothesized for low-income groups, significantly advantageous survival in Toronto was observed for both breast cancer (SRR=1.06) and prostate cancer (SRR=1.10). Also as hypothesized, the Toronto advantage was much smaller than had been observed with its previous comparison with Detroit; the corresponding Toronto-Detroit breast and prostate SRRs were 1.30 and 1.21. 1 Consistent with a health insurance explanation for the observed SES-cancer survival associations in the United States, along with the observed survival advantages among Canadians who live in relatively low-income areas compared with their US counterparts, most such associations were larger when the analysis was restricted to patients diagnosed before the age of 65 years who were not yet eligible for Medicare coverage in the United States (bottom of Table 2 ). Among these younger breast cancer cohorts, which made up 61% of this study's sample of women with breast cancer, the low-income vs high-income SRR in Honolulu was 0.88 (the middle-income vs high-income SRR approached statistical significance [0.93]). Among low-income groups, even better survival was observed in Toronto vs Honolulu (SRR=1.12) than had been observed among the breast cancer cases involving patients of all ages. None of the within-country or between-country breast cancer survival comparisons were significant among the sample of women 65 years or older (not shown in Table 2 ). As for the younger prostate cancer cohorts, which made up only 18% of the sample of men with prostate cancer, a remarkably similar pattern of within-and between-country disadvantage among Honolulu's relatively poor was observed, although it was generally characterized by point estimates that approached statistical significance and nonsignificant trends. Unlike older women with breast cancer, older prostate cancer patients in relatively lowincome areas remained disadvantaged regarding 5-year cancer survival compared with their counterparts in relatively high-income areas (SRR = 0.87; 95% confidence interval [95% CI]=0.77, 0.99).
We then expanded these analyses across income decile groups to characterize cancer survival differences across more diverse socioeconomic areas, from the categorically most affluent to the most impoverished underclass neighborhoods ( Table 3 ). The following 3 patterns, of interest with regard to health care policy, emerged from this systematic replication.
1. Even with greatly expanded socioeconomic variability across 10 income areas, no association was observed between SES and cancer survival in the Canadian sample; the stark similarity of breast and prostate cancer survival in Toronto was maintained, even when the lowestincome decile was compared with the highest.
2. The poorest US income areas were extremely disadvantaged compared with the most affluent ones; 5-year survival rates were significantly lower in Honolulu's lowest-income areas (breast and prostate cancer lowest-income vs highest-income decile SRRs were 0.78 and 0.69, respectively). Among the Honolulu sample of women younger than 65 years with breast cancer, the socioeconomic survival gradient was even larger (lowest-income vs highestincome decile SRR=0.69; 95% CI=0.52, 0.91; not shown in Table 3 ).
Consistent with previous tertile-based
analyses, significantly advantageous survival among the lowest-income groups in Toronto was observed for both breast cancer (SRR = 1.20) and prostate cancer (SRR=1.24).Among women younger than 65 years with breast cancer, the estimate of advantaged Canadian survival was even greater (SRR=1.28; 95% CI= 1.07, 1.53; not shown in Table 3 ).
It is also important to note that a pattern of diminished survival typically approaching statistical significance was observed among Honolulu's breast and prostate cancer patients who lived in Honolulu's fifth through eighth income deciles, which may be categorically defined as representing middle-class to lowermiddle-or working-class neighborhoods (SRRs ranged from 0.80 to 0.90). Relatedly, in the sixth decile, fewer such middle-income women with breast cancer survived for 5 years than did their Canadian counterparts (SRR= 1.10). Finally, the Toronto-Honolulu breast cancer (SRR=0.91) and prostate cancer (SRR= 0.89) SRR estimates that approached statistical significance and were nonsignificant, respectively, suggested that among the most economically resourceful cancer patients who live in the wealthiest 10% of North American neighborhoods, Americans may enjoy a survival advantage. 
Discussion
We studied the effect of SES on survival from breast and prostate cancer among the adult populations ofToronto, Ontario, and Honolulu, Hawaii. In within-country comparisons, breast and prostate cancer survival in Honolulu was significantly poorer (on the basis of 95% confidence interval) among people from lower socioeconomic areas. These SES-survival associations were larger for steeper socioeconomic gradients (income deciles vs tertiles) and among younger breast cancer patients (younger than 65 years) not yet eligible for Medicare participation. No such associations were found among Toronto's population. In the between-country analysis that compared cases arising from Toronto and Honolulu's low-income areas (lowest third and lowest tenth), we found a consistently significant survival advantage inToronto that was, again, even larger among younger breast cancer patients. Furthermore, we found more tentative evidence of a smaller survival advantage in Toronto among some categorical middle-class patients and a concomitant advantage in the United States among some upperclass patients.
This pattern of findings points toward the different health care systems in Canada and the United States (single-payer vs multipayer) as its most cogent explanation. Because of Hawaii's more prevalent health insurance coverage, we predicted (correctly) that it would have a cancer survival experience more similar to a that of a Canadian sample than US samples in previous Canadian-US comparative studies had. This study's general pattern of results, along with its somewhat attenuated observed associations, substantiates the health insurance hypothesis as an explanation for Canadian-US differences on cancer survival, particularly among the relatively poor but also among middle-class and more affluent cancer patients.
Among the poor, this study's findings are consistent with the well-known strong associations of health insurance status-no insurance or underinsured vs some or adequate coverage-with SES in the United States. 42 Notwithstanding questions about the relative effectiveness of Medicaid, America's health care program for the poor, this study's relatively poor areas contained almost 2 "nearpoor" people (up to 200% of the federally established poverty criterion) for each of their poor residents. Many such marginally impoverished people, while generally not meeting Medicaid's means test, probably have difficulty purchasing private health insurance. As for this study's middle-class or working-class neighborhoods, these also include significant enclaves of the near poor (2-fold to 3-fold more prevalent than the poor in this study's US sample), including the working poor as well as better-off working people who, for a number of social structural and economic reasons, remain uninsured or underinsured. 42 The tentative evidence that American cancer survival advantage is enjoyed by only a very select few-that is, the most affluent 10% of the populationonly serves to further indict the American health care system. It seems to suggest that only the most fortunate, generally well-insured people with ample disposable incomes can expect the best that the US health care system has to offer.
Hawaii's pattern of cancer survival, which is more similar to that of Canada, and its smaller SES-cancer survival gradients are different from what has been observed in other states (California, Connecticut, Michigan, and Washington). [1] [2] [3] These findings are certainly consistent with Hawaii's much greater prevalence of health insurance coverage; they are also consistent with secular trends within Hawaii. Whereas others have recently found no association between SES and breast cancer survival in Hawaii, the gradient most typical of other states (lower survival rates among the poor) was observed there in earlier cohorts from the 1960s through 1970s. 43, 44 The previously observed pattern of advantaged Hawaiian cancer survival within the United States is also consistent with this study's findings. 45 It is possible-but, we think, improbable-that other factors may account for this study's findings. In addition to its unique health insurance system, Hawaii also has a relatively unique ethnic distribution and at least the suggestion of a significantly different lifestyle than elsewhere.
As elsewhere, race/ethnicity and lifestyle factors such as diet and smoking have been observed to be associated with the occurrence and prognosis of some cancers, [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] although the effects, particularly for survival, may generally be categorized as very small. The majority of cancer case patients we studied in Honolulu were Asian Americans or Pacific Islanders (63%); most of the others were White (32%). 37, 38 It was not possible to mathematically adjust for this factor, as the Ontario Cancer Registry does not routinely code race/ethnicity. However, we did replicate the between-country comparisons with the non-White and White Honolulu cohorts. Although there were some power problems, these analyses did not result in any practical alteration of our findings. We think that the ethnicity/ lifestyle hypotheses are not particularly potent alternative explanations, for a number of other reasons.
1. The findings within Hawaii were as divergent from those of other states, as were the between-country ones.
2. Asian Americans and Pacific Islanders are by no means a homogeneous group of people. In fact, evidence suggests that regarding breast cancer survival among Hawaiian residents, for example, Native Hawaiian, Filipino, and Chinese people may be disadvantaged relative to Whites, while Japanese people are advantaged. 49 3. Toronto may also be generally characterized as a multicultural population, although not to the same degree as Honolulu. Approximately a third of Toronto's residents are people of color, and nearly one quarter of them emigrated during the past 10 years. 35 4. The so-called Hawaiian lifestyle seems to be based more in mythology than empiricism. The prevalence of actual relevant risky behaviors (lack of exercise, overweight, smoking, and excessive alcohol consumption) among Hawaiians has been observed to be strikingly similar to that of most other states. 56 Therefore, whatever influences ethnicity and lifestyle impart in such survival analyses, they are not likely to be systematic, and so they are not likely to confound this study's findings.
In fact, we believe that if there is any bias in this study's Canada-US comparative analyses of low-income groups, it is probably that its SRR point estimates are underestimates of the truth, for the following reasons.
1. Whereas both female life expectancy and male life expectancy at birth are more than 2 years greater in Canada than in the United States, these figures are more than 3 years greater for Honolulu than for Toronto. [57] [58] [59] [60] 2. Any information bias due to ecologic measurement of SES is likely to be similarly nondifferential among this study's Canadian and US samples 1-3,5,61-70 ; relatedly, owing to this study's focus on 10 socioeconomic areas (in Honolulu, median household incomes in these areas in 1990 ranged from $21 420 to $61384), actual socioeconomic variability, and therefore the ability to detect meaningful effects, was substantially diminished (Honolulu median incomes across its 190 census tracts ranged from $5000 to $149850).
3. In focusing on all-cause rather than cancer-specific censored survival, this study used a more conservative analytic approach, in that cancer-specific death rates may underestimate the mortality associated with a diagnosis of cancer. 71 Recall also that cancer was the underlying cause of the vast majority of deaths, particularly among the younger cohort not eligible for Medicare. Moreover, the underlying cause of the majority of "noncancer" deaths-respiratory and circulatory problems-can often be directly associated with the treatment of cancer or, for that matter, with its nontreatment. We therefore believe that this study's findings are best characterized as conservative estimates of Canadian-US cancer outcome differences.
Conclusions
This study's central finding of advantaged Canadian vs American cancer survival, particularly among relatively low-income groups, implicates health care systemic factors as its most cogent explanation. Although Hawaii's prevalent health insurance coverage does seem attendant with better management of cancer care than that of other states, people with cancer in Toronto still enjoy a significant survival advantage. Employer-mandated health insurance coverage certainly seems to be a large step toward providing more equitable health care. However, this study provides evidence to suggest that even better care could be expected among more Americans through movement to a more universally accessible, single-payer system such as Canada's.
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